Cuin a bhios Sarepta Therapeutics, Inc. a 'foillseachadh aithris prothaid is call?
Tha aithris prothaid is call Sarepta Therapeutics, Inc. air fhoillseachadh aon uair sa cheathramh; chaidh an aithisg mu dheireadh de thoraidhean ionmhais Sarepta Therapeutics, Inc. fhoillseachadh air 31/03/2021.
Dè a 'phrothaid bho na h-earrannan de Sarepta Therapeutics, Inc.?
B 'e tuairmse de chosnaidhean gach roinn de Sarepta Therapeutics, Inc. -2.1 $ anns an aithisg ionmhais mu dheireadh.
Cuin a dh'fhoillsicheas Sarepta Therapeutics, Inc. an ath aithris prothaid agus call?
Bidh an ath aithisg air a 'chunntas prothaid is call Sarepta Therapeutics, Inc. air An t-Ògmhios 2024.
Tha Sarepta Therapeutics, Inc. cosnadh gach cuibhreann de bhuidheann ionmhais na thaisbeanair àireamhaichte de shoirbheachas companaidh, ceangailte ri luach na buidhne fhèin. Cosnadh gach cuibhreann - luach air a thomhas: tha a ’phrothaid iomlan airson na h-ùine aithris air a roinn leis an àireamh de earrannan a th’ ann. Tha e soilleir gu bheil cosnadh Sarepta Therapeutics, Inc. gach roinn na fheart ionmhasail airson ùine sònraichte. Prothaid Sarepta Therapeutics, Inc. - prothaid aithris na buidhne airson an àm ionmhais a tha air a shònrachadh leis an lagh.
|
Brabac Sarepta Therapeutics, Inc.
Tha na prothaidean Sarepta Therapeutics, Inc. nan iomradh. Chan eil e cho cudromach do luchd-earrannan prìobhaideach. Is e comharra mòran nas inntinniche cosnadh gach cuibhreann, a bheir buaidh dhìreach air na tha de earrannan ann an gach roinn. Tha ceann-latha na h-aithisg prothaid Sarepta Therapeutics, Inc. ceangailte ri reachdas dùthaich clàraidh a ’chompanaidh. Tha cinn-latha aithrisean prothaid Sarepta Therapeutics, Inc. airson amannan o chionn ghoirid air an sealltainn ann an clàr agus graf na seirbheis air-loidhne againn.
|
Prothaid ràitheil Sarepta Therapeutics, Inc.
Cosnadh gach cuibhreann Sarepta Therapeutics, Inc. air a thomhas le bhith a ’roinn teachd-a-steach lom leis an àireamh de earrannan sa chompanaidh. Tha cosnadh gach cuibhreann Sarepta Therapeutics, Inc. na chomharradh air àm ionmhais sònraichte. Tha e furasta a bhith a ’tomhas gu bheil an ùine ionmhais a’ dol aig an aon àm ri foillseachadh aithrisean ionmhais air prothaid. Gheibhear Sarepta Therapeutics, Inc. cosnadh gach cuibhreann airson na h-ùine aithris mu dheireadh anns a ’chlàr againn (an t-sreath as àirde) no graf (an colbh as fhaide air falbh). Is e Sarepta Therapeutics, Inc. cosnadh ràitheil airson anailisean ionmhasail am prìomh aithisg eadar-amail airson na bliadhna ionmhais.
|
|
Ceann-là aithisg SRPT
|
Tuarastal airson gach roinn
Tha tuarastalan gach co-roinn air an tomhas le bhith a 'roinneadh teachd-a-steach (no prothaid) lìon le àireamh nan earrannan den chompanaidh.
|
Atharrachadh airson na bliadhna %
|
|
31/03/2021 |
-2.1 USD |
- |
|
31/12/2020 |
-2.4 USD |
- |
|
30/09/2020 |
-2.5 USD |
+47.06% ↑ |
|
30/06/2020 |
-1.93 USD |
-48.396% ↓ |
|
30/09/2019 |
-1.7 USD |
-40.179% ↓ |
|
30/06/2019 |
-3.74 USD |
-35.0854% ↓ |
|
31/03/2019 |
-1.07 USD |
-81.255% ↓ |
|
31/12/2018 |
-2.05 USD |
-68.75% ↓ |
|
30/09/2018 |
-1.15 USD |
-4.767% ↓ |
|
30/06/2018 |
-1.67 USD |
-2.1058% ↓ |
|
31/03/2018 |
-0.55 USD |
-0.628% ↓ |
|
31/12/2017 |
-0.37 USD |
-75.962% ↓ |
|
30/09/2017 |
-0.76 USD |
-35.532% ↓ |
|
30/06/2017 |
-0.46 USD |
-23.872% ↓ |
|
31/03/2017 |
-0.71 USD |
-75.334% ↓ |
|
31/12/2016 |
-0.87 USD |
-11.0106% ↓ |
|
30/09/2016 |
-1.18 USD |
-10.293% ↓ |
|
30/06/2016 |
-1.35 USD |
-1.716% ↓ |
|
31/03/2016 |
-1.31 USD |
-21.72% ↓ |
|
31/12/2015 |
-1.44 USD |
-30.904% ↓ |
|
30/09/2015 |
-1.25 USD |
-18.998% ↓ |
|
30/06/2015 |
-1.01 USD |
-37.626% ↓ |
|
31/03/2015 |
-1.49 USD |
-20.683% ↓ |
|
31/12/2014 |
-1.08 USD |
-14.86% ↓ |
|
30/09/2014 |
-0.71 USD |
-32.258% ↓ |
|
30/06/2014 |
-0.85 USD |
-19.574% ↓ |
|
31/03/2014 |
-0.75 USD |
-22.118% ↓ |
|
31/12/2013 |
-0.23 USD |
-57.744% ↓ |
|
30/09/2013 |
-1.24 USD |
-55.985% ↓ |
|
30/06/2013 |
-0.6 USD |
-50.336% ↓ |
|
31/03/2013 |
-1.32 USD |
-29.127% ↓ |
|
31/12/2012 |
-2.36 USD |
-11.112% ↓ |
|
30/09/2012 |
-0.3 USD |
-18.571% ↓ |
|
30/06/2012 |
0.35 USD |
-23.611% ↓ |
|
31/03/2012 |
-0.78 USD |
-56.364% ↓ |
|
31/12/2011 |
-0.06 USD |
-21.429% ↓ |
|
30/09/2011 |
-0.18 USD |
-2.778% ↓ |
|
30/06/2011 |
0.06 USD |
-24.242% ↓ |
|
31/03/2011 |
0.12 USD |
-28.889% ↓ |
|
31/12/2010 |
-0.42 USD |
-35.714% ↓ |
|
30/09/2010 |
-0.42 USD |
-7.692% ↓ |
|
30/06/2010 |
-0.9 USD |
-60% ↓ |
|
31/03/2010 |
-0.06 USD |
- |
|
31/12/2009 |
0.18 USD |
-25% ↓ |
|
30/09/2009 |
-0.48 USD |
- |
|
30/06/2009 |
-1.38 USD |
-73.333% ↓ |
|
31/03/2009 |
-0.06 USD |
-40% ↓ |
|
31/12/2008 |
-0.06 USD |
-25% ↓ |
|
30/09/2008 |
-0.48 USD |
-45.833% ↓ |
|
30/06/2008 |
-0.12 USD |
-40% ↓ |
|
31/03/2008 |
-1.38 USD |
-42.308% ↓ |
|
31/12/2007 |
-0.42 USD |
-42.857% ↓ |
|
30/09/2007 |
-0.78 USD |
-14.286% ↓ |
|
30/06/2007 |
-0.96 USD |
-12% ↓ |
|
31/03/2007 |
-1.08 USD |
-53.846% ↓ |
|
31/12/2006 |
-0.96 USD |
-25% ↓ |
|
30/09/2006 |
-0.78 USD |
-9.524% ↓ |
|
30/06/2006 |
-0.78 USD |
-5.714% ↓ |
|
31/03/2006 |
-1.08 USD |
-50% ↓ |
|
31/12/2005 |
-0.6 USD |
-27.586% ↓ |
|
30/09/2005 |
-0.24 USD |
-9.524% ↓ |
|
30/06/2005 |
-0.66 USD |
-43.0894% ↓ |
|
31/03/2005 |
-0.78 USD |
-11.111% ↓ |
|
31/12/2004 |
-0.84 USD |
-1.136% ↓ |
|
30/09/2004 |
-0.84 USD |
-4.762% ↓ |
|
30/06/2004 |
-1.2 USD |
-41.463% ↓ |
|
31/03/2004 |
-1.26 USD |
-18.182% ↓ |
|
31/12/2003 |
-1.26 USD |
-31.783% ↓ |
|
30/09/2003 |
-0.9 USD |
- |
|
30/06/2003 |
-0.72 USD |
-33.333% ↓ |
|
31/03/2003 |
-0.78 USD |
-2.941% ↓ |
|
31/12/2002 |
-0.9 USD |
- |
|
30/09/2002 |
-1.2 USD |
- |
|
30/06/2002 |
-1.8 USD |
- |
|
31/03/2002 |
-1.98 USD |
- |
Tha Sarepta Therapeutics, Inc. cosnadh gach ràithe cuideachd mar aon de chomharran prothaid na buidhne, ged nach eil e cho mòr-chòrdte ri cosnadh bliadhnail gach cuibhreann. Is e a ’phrothaid ràitheil mu dheireadh Sarepta Therapeutics, Inc. an-diugh a’ phrothaid a chaidh ainmeachadh gu h-oifigeil airson a ’cheathramh iomraidh mu dheireadh. Tha atharrachadh ann an prothaid Sarepta Therapeutics, Inc. airson na bliadhna na luach àireamhaichte airson fiosrachadh a bharrachd a tha a ’sealltainn an atharrachadh sa cheud de phrothaid leis an aon eadar-ama den bhliadhna mu dheireadh. Dh ’fhaodadh gum bi atharrachadh ann an prothaid ràitheil Sarepta Therapeutics, Inc. an coimeas ris an-uiridh cudromach do chompanaidhean le gnìomhachas ràitheil. Ach is e am prìomh chomharradh air prothaid na companaidh an atharrachadh bliadhnail ann am prothaid.
Tha an atharrachadh ann an prothaid air a shealltainn mar cheudad. Tha eachdraidh prothaid Sarepta Therapeutics, Inc. airson bliadhnaichean roimhe air a thoirt seachad anns a ’chlàr againn“ Prothaid ràitheil ”. Sarepta Therapeutics, Inc. tha eachdraidh cosnaidh ràitheil ri fhaighinn air-loidhne thairis air na 10 bliadhna a dh ’fhalbh. Tha Sarepta Therapeutics, Inc. stòr-dàta prothaid air-loidhne airson amannan ùine air a chur ri chèile bho stòran oifigeil dearbhte fad na h-ùine.
|
